Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-26 @ 12:49 AM
NCT ID: NCT03254134
Description: This is a cohort study using based on existing data; therefore, it is not feasible to make a causality assessment at the individual case level.
Frequency Threshold: 5
Time Frame: None
Study: NCT03254134
Study Brief: Comparative Effectiveness and Safety Between Warfarin and Dabigatran
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dabigatran Patients prescribed dabigatran as the first Oral Anticoagulants (OACs) with nonvalvular atrial fibrillation. 0 None 0 0 0 0 View
Warfarin Patients prescribed warfarin as the first Oral Anticoagulants (OACs) with nonvalvular atrial fibrillation. 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):